These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34443334)

  • 1. Quinoxaline Moiety: A Potential Scaffold against
    Montana M; Montero V; Khoumeri O; Vanelle P
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443334
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
    Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
    Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinoxaline and quinoxaline-1,4-di-N-oxides: An emerging class of antimycobacterials.
    Keri RS; Pandule SS; Budagumpi S; Nagaraja BM
    Arch Pharm (Weinheim); 2018 May; 351(5):e1700325. PubMed ID: 29611626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-
    Palos I; Luna-Herrera J; Lara-Ramírez EE; Loera-Piedra A; Fernández-Ramírez E; Aguilera-Arreola MG; Paz-González AD; Monge A; Wan B; Franzblau S; Rivera G
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
    Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.
    Vicente E; Villar R; Burguete A; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3321-6. PubMed ID: 18625764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity.
    Raphoko LA; Lekgau K; Lebepe CM; Leboho TC; Matsebatlela TM; Nxumalo W
    Bioorg Med Chem Lett; 2021 Mar; 35():127784. PubMed ID: 33422606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
    Ramalingam P; Ganapaty S; Rao ChB
    Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
    Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
    Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages.
    Zhang H; Lu Q; Zhang J; Qu W; Xie S; Huang L; Yuan Z; Pan Y
    Eur J Med Chem; 2021 Nov; 223():113657. PubMed ID: 34217060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
    Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
    Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoxaline 1,4-di-N-Oxide Derivatives: Are They Unselective or Selective Inhibitors?
    Rivera G
    Mini Rev Med Chem; 2022; 22(1):15-25. PubMed ID: 33573542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinoxaline Derivatives as Antiviral Agents: A Systematic Review.
    Montana M; Montero V; Khoumeri O; Vanelle P
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
    Santivañez-Veliz M; Pérez-Silanes S; Torres E; Moreno-Viguri E
    Bioorg Med Chem Lett; 2016 May; 26(9):2188-93. PubMed ID: 27025343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
    Puratchikody A; Natarajan R; Jayapal M; Doble M
    Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in design of potential quinoxaline anti-infectives.
    Jampilek J
    Curr Med Chem; 2014; 21(38):4347-73. PubMed ID: 25312209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
    Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A
    Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.